Abstract
Inhibition of the protein chaperone Hsp90 is a promising new approach to cancer therapy. We describe the preparation of potent non-benzoquinone ansamycins. One of these analogues, generated by feeding 3-amino-5-chlorobenzoic acid to a genetically engineered strain of Streptomyces hygroscopicus, shows high accumulation and long residence time in tumor tissue, is well-tolerated upon intravenous dosing, and is highly efficacious in the COLO205 mouse tumor xenograft model.
Original language | English (US) |
---|---|
Pages (from-to) | 1518-1521 |
Number of pages | 4 |
Journal | Journal of medicinal chemistry |
Volume | 52 |
Issue number | 6 |
DOIs | |
State | Published - Mar 26 2009 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery